Drug Profile
Hepatitis A vaccine - American Biogenetic Sciences
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator American Biogenetic Sciences [CEASED]
- Class Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis A
Most Recent Events
- 20 Sep 2002 Discontinued - Preclinical for Hepatitis A in USA (unspecified route)
- 16 Aug 2000 No-Development-Reported for Hepatitis A in USA (Unknown route)
- 22 Mar 1994 Preclinical development for Hepatitis A in USA (Unknown route)